Y

Yantai Dongcheng Biochemicals Co Ltd
SZSE:002675

Watchlist Manager
Yantai Dongcheng Biochemicals Co Ltd
SZSE:002675
Watchlist
Price: 12.76 CNY -4.99% Market Closed
Market Cap: 10.5B CNY
Have any thoughts about
Yantai Dongcheng Biochemicals Co Ltd?
Write Note

Relative Value

The Relative Value of one Yantai Dongcheng Biochemicals Co Ltd stock under the Base Case scenario is 22.73 CNY. Compared to the current market price of 12.76 CNY, Yantai Dongcheng Biochemicals Co Ltd is Undervalued by 44%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
22.73 CNY
Undervaluation 44%
Relative Value
Price
Y
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
49
vs Industry
72
Median 3Y
3.6
Median 5Y
3.8
Industry
7.7
Forward
3.2
vs History
14
vs Industry
4
Median 3Y
58.1
Median 5Y
58.1
Industry
22.7
Forward
41.9
vs History
11
vs Industry
3
Median 3Y
15.8
Median 5Y
18.5
Industry
21.6
vs History
vs Industry
1
Median 3Y
23.4
Median 5Y
32.3
Industry
25.2
vs History
69
vs Industry
42
Median 3Y
2.5
Median 5Y
2.7
Industry
2.5
vs History
53
vs Industry
60
Median 3Y
3.7
Median 5Y
4
Industry
7.7
Forward
3.3
vs History
47
vs Industry
42
Median 3Y
8.6
Median 5Y
8.8
Industry
9
vs History
7
vs Industry
4
Median 3Y
29.2
Median 5Y
27.7
Industry
4.2
Forward
17.1
vs History
7
vs Industry
4
Median 3Y
29.2
Median 5Y
27.7
Industry
4.1
Forward
16.9
vs History
11
vs Industry
3
Median 3Y
16.7
Median 5Y
19.2
Industry
5.7
vs History
vs Industry
0
Median 3Y
28.4
Median 5Y
30.1
Industry
3.6
vs History
90
vs Industry
52
Median 3Y
1.8
Median 5Y
2
Industry
4.6

Multiples Across Competitors

Competitors Multiples
Yantai Dongcheng Biochemicals Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Yantai Dongcheng Biochemicals Co Ltd
SZSE:002675
10.5B CNY 3.6 76.7 35.5 35.5
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 083 264.3 -181 004.1 -219 796.6 -217 288.5
US
Abbvie Inc
NYSE:ABBV
312.7B USD 5.6 61.5 15.3 23.6
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 4.9 37.4 17.5 33.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 10.9 -241.6 24 25.2
US
Gilead Sciences Inc
NASDAQ:GILD
112.4B USD 4 891.9 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 849.9 -472 -514.1 -500.3
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 5.9 17.8 16.2 18
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.6 -58.7 -53
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.5 -129.9 -104.5 -76.2
P/E Multiple
Earnings Growth
CN
Y
Yantai Dongcheng Biochemicals Co Ltd
SZSE:002675
Average P/E: 186.4
76.7
88%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -181 004.1 N/A
US
Abbvie Inc
NYSE:ABBV
61.5
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -241.6
42%
US
Gilead Sciences Inc
NASDAQ:GILD
891.9
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.6 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
CN
Y
Yantai Dongcheng Biochemicals Co Ltd
SZSE:002675
Average EV/EBITDA: 19.8
35.5
167%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 796.6 N/A
US
Abbvie Inc
NYSE:ABBV
15.3
29%
US
Amgen Inc
NASDAQ:AMGN
17.5
62%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
43%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
16%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.1 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
35%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
EV/EBIT Multiple
EBIT Growth
CN
Y
Yantai Dongcheng Biochemicals Co Ltd
SZSE:002675
Average EV/EBIT: 24.4
35.5
104%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 288.5 N/A
US
Abbvie Inc
NYSE:ABBV
23.6
88%
US
Amgen Inc
NASDAQ:AMGN
33.1
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -500.3 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.2 N/A

See Also

Discover More
Back to Top